CD134 antibody [OX-40]
GTX42439
ApplicationsFlow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
TargetTnfrsf4
Overview
- SupplierGeneTex
- Product NameCD134 antibody [OX-40]
- Delivery Days Customer9
- Application Supplier NoteFACS: 1/10-1/50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDOX-40
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID25572
- Target nameTnfrsf4
- Target descriptionTNF receptor superfamily member 4
- Target synonymsOx40, Txgp1, tumor necrosis factor receptor superfamily member 4, MRC OX40, OX40 antigen, OX40L receptor, Tax-transcriptionally activated glycoprotein 1, tumor necrosis factor (ligand) superfamily member 4, tumor necrosis factor receptor superfamily, member 4, tumor necrosis factor superfamily, member 4
- HostMouse
- IsotypeIgG2b
- Protein IDP15725
- Protein NameTumor necrosis factor receptor superfamily member 4
- Scientific Descriptionmembrane-bound receptor, binds adaptor proteins Traf2 and Traf5; member of the tumor necrosis factor (TNF)-receptor superfamily [RGD, Feb 2006]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Snelgrove RJ, Cornere MM, Edwards L, et al. OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection. J Infect Dis. 2012,205(6):975-83. doi: 10.1093/infdis/jir868Read this paper
- Thaunat O, Graff-Dubois S, Brouard S, et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS One. 2010,5(6):e11398. doi: 10.1371/journal.pone.0011398Read this paper
- Volovitz I, Marmor Y, Mor F, et al. T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells. J Autoimmun. 2010,35(2):135-44. doi: 10.1016/j.jaut.2010.05.003Read this paper
- Albillos A, Nieto M, Ubeda M, et al. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis. Gut. 2010,59(7):943-52. doi: 10.1136/gut.2008.168831Read this paper
- Giorgini A, Noble A. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. J Leukoc Biol. 2007,82(5):1053-61.Read this paper
- Cousins L, Graham M, Tooze R, et al. Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene. Gastroenterology. 2006,131(5):1475-85.Read this paper
- Stephens LA, Barclay AN, Mason D. Phenotypic characterization of regulatory CD4+CD25+ T cells in rats. Int Immunol. 2004,16(2):365-75.Read this paper
- Humphreys IR, Walzl G, Edwards L, et al. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med. 2003,198(8):1237-42.Read this paper
- Lavelle EC, McNeela E, Armstrong ME, et al. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol. 2003,171(5):2384-92.Read this paper
- Walker LS, Gulbranson-Judge A, Flynn S, et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J Exp Med. 1999,190(8):1115-22.Read this paper


